TOKYO,March 4,2025-- In a display of global city strategy,the governors of Tokyo and Bangkok have lined up to tackle climate-linked natural disasters,an aging and shrinking population,and other challe
READ MOREBEIJING,March 4,2025--A report from People\'s Daily: Lately,there has been much talk about foreign investors withdrawing from China on a large scale. Official data show that in 2024,foreign direct inv
SINGAPORE,March 5,2025-- Synpulse,a global professional services provider to major banking and financial institutions,is proud to announce the appointment of Nick Wilde as Senior Advisor. Nick\'s exp
Humanoid robotics,GB300 NVL72 infrastructure & digital twins scaling out AI factories TAIPEI and SAN JOSE,Calif.,March 19,2025-- Hon Hai Technology Group ("Foxconn") (TWSE:2317) today u
SAN JOSE,Calif.,March 19,2025-- MSI,a leading global provider of high-performance server solutions,showcased its cutting-edge 4U and 2U AI platforms built on the NVIDIA MGXreference architecture at GT
SHANGHAI,March 19,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on developing innovative CAR T-cell therapies,announced its 2024 Annual Results.
Annual Volume Increasedto 34.0Billion Parcels RMB10.2BillionFull YearAdjusted Net Income Grew 12.7% US$0.35per Share Semi-Annual Dividend Announced
Built withNVIDIA AI,Cohesity Solution Features Validated Reference Architectures for Use with Cisco UCS,Hewlett Packard Enterprise,and Nutanix
The premier event is designed to advance the industry with hands-on generative AI experiences,expert-led sessions and opportunities to connect with today\'s leading legal data innovators
HONG KONG,March 17,2025-- CLPe today (March 17) signed a Memorandum of Understanding (MoU) with a leading Mainland manufacturer of construction machinery Zoomlion Heavy Industry Science and Technology
SHANGHAI,March 17,2025--The HERO ESPORTS Asian Champions League (ACL),Asia\'s premier multi-title esports tournament hosted by Asia\'s leading Esports company Hero Esports,has announced that a total o
Fourth-Quarter Revenue Reached RMB11,539 Million,Up 6.9% Year-over-Year 2024 Revenue Reached RMB39,241 Million,Up 5.2% Year-over-Year (Excluding COVID-19 Commercial Project of 2023)
SHANGHAI,March 17,2025--Rona Therapeutics Inc.,a global leader in RNA-targeted therapeutics,announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA)
© OfficialAffairs
